发明名称 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRIDAE VIRAL INFECTIONS
摘要 A compound is selected from the structural formulae depicted in FIG. 1 or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises a compound selected from the structural formulae depicted in FIG. 1 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier of excipient. A method of treating a HCV infection in a subject comprises administering to the subject a therapeutically effective amount of selected from the structural formulae depicted in FIG. 1 or a pharmaceutically acceptable salt thereof. A method of inhibiting or reducing the activity of HCV polymerase in a subject or in a biological in vitro sample comprises administering to the subject or to the sample a therapeutically effective amount of selected from the structural formulae depicted in FIG. 1 or a pharmaceutically acceptable salt thereof.
申请公布号 WO2012024363(A2) 申请公布日期 2012.02.23
申请号 WO2011US48027 申请日期 2011.08.17
申请人 VERTEX PHARMACEUTICALS INCORPORATED;GREEN, JEREMY;KONG, LAVAL, CHAN CHUN;DAS, SANJOY, KUMAR;POISSON, CARL;NANTHAKUMAR, SUGANTHINI;WAAL, NATHAN;LI, PAN;RONKIN, STEVEN;LAUFFER, DAVID, J.;WILSON, DEAN, M. 发明人 GREEN, JEREMY;KONG, LAVAL, CHAN CHUN;DAS, SANJOY, KUMAR;POISSON, CARL;NANTHAKUMAR, SUGANTHINI;WAAL, NATHAN;LI, PAN;RONKIN, STEVEN;LAUFFER, DAVID, J.;WILSON, DEAN, M.
分类号 C07D333/38;A61K31/381;A61P31/12;C07D333/40;C07D409/06;C07D409/12;C07D413/12;C07D417/12 主分类号 C07D333/38
代理机构 代理人
主权项
地址